• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Chemother . Comparative study of rapid antigen testing and two nucleic acid amplification tests for influenza virus detection

tetano

Editor, Senior Moderator
J Infect Chemother


. 2022 Apr 12;S1341-321X(22)00118-0.
doi: 10.1016/j.jiac.2022.04.009. Online ahead of print.
Comparative study of rapid antigen testing and two nucleic acid amplification tests for influenza virus detection


Yuki Sato[SUP] 1 [/SUP], Shinya Nirasawa[SUP] 2 [/SUP], Masachika Saeki[SUP] 2 [/SUP], Yuki Yakuwa[SUP] 2 [/SUP], Mayumi Ono[SUP] 2 [/SUP], Ryo Kobayashi[SUP] 1 [/SUP], Hirotaka Nakafuri[SUP] 2 [/SUP], Ryosei Murai[SUP] 2 [/SUP], Yoshihiro Fujiya[SUP] 3 [/SUP], Koji Kuronuma[SUP] 4 [/SUP], Satoshi Takahashi[SUP] 5 [/SUP]



Affiliations

Abstract

Introduction: This study aimed to evaluate rapid antigen detection (RAD) and rapid nucleic acid amplification tests (NAATs) to detect influenza virus (IV).
Methods: The conventional RAD test (Quick Chaser Flu A, B: QC), using silver amplified immunochromatography (Quick Chaser Auto Flu A, B: QCA), as well as two NAATs (Xpert Xpress Flu/RSV: Xpert, cobas Influenza A/B & RSV: cobas) were evaluated using nasopharyngeal swabs from suspected cases of influenza. A reference method was performed using real-time reverse transcription polymerase chain reaction according to the manual of the Japanese National Institute of Infectious Disease (NIID).
Results: From a total of 177 samples, 51 were positive according to the NIID assay. The kappa (κ) coefficient in Xpert and cobas for influenza A virus (IAV)/influenza B virus (IBV) was 1.00, which was the highest among the four detection assays. However, the κ coefficients in QC and QCA for IAV/IBV were 0.71-0.77 and 0.87-0.89, respectively. The sensitivities of the RAD tests were 41.7% in QC and 50.0% in QCA at < 6 h after onset, and 100.0% in both QC and QCA at 24-48 h after onset. The cycle threshold (Ct) values were significantly lower in the group in which all detection assays were positive for IAV.
Conclusions: Xpert and cobas have comparable analytical performances and are highly useful as influenza virus detection assays. QC and QCA could show false negatives frequently in the early stage of infection and when viral load is low.

Keywords: Influenza virus; Nucleic acid amplification test; Rapid antigen test; Real-time RT-PCR; Sensitivity.
 
Back
Top Bottom